Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jul 15;59(1):16-20.
doi: 10.1002/pbc.23416. Epub 2011 Nov 18.

Prevention of bacterial infection in pediatric oncology: what do we know, what can we learn?

Sarah Alexander  1 , Michael Nieder, Danielle M Zerr, Brian T Fisher, Christopher C Dvorak, Lillian Sung
Affiliations

Prevention of bacterial infection in pediatric oncology: what do we know, what can we learn?

Sarah Alexander et al. Pediatr Blood Cancer. .

Abstract

Bacterial sepsis continues to be a leading cause of morbidity and toxic death in children receiving intensive therapy for cancer. Empiric therapy for suspected infections and treatment of documented infections are well-established standards of care. The routine use of prophylactic strategies is much less common in pediatric oncology. This paper will review the current literature on the use and risks of antimicrobial prophylaxis as well as non-pharmacological methods for infection prevention and will address areas in need of further research.

PubMed Disclaimer

References

    1. Kuderer NM, Dale DC, Crawford J, et al. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer. 2006;106:2258–2266. - PubMed
    1. Sung L, Aplenc R, Zaoutis T, et al. Infections in pediatric acute myeloid leukemia: Lessons learned and unresolved questions. Pediatr Blood Cancer. 2008;51:458–460. - PubMed
    1. Creutzig U, Zimmermann M, Reinhardt D, et al. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: Analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol. 2004;22:4384–4393. - PubMed
    1. Sung L, Lange BJ, Gerbing RB, et al. Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia. Blood. 2007;110:3532–3539. - PubMed
    1. Saarinen-Pihkala UM, Heilmann C, Winiarski J, et al. Pathways through relapses and deaths of children with acute lymphoblastic leukemia: Role of allogeneic stem-cell transplantation in Nordic data. J Clin Oncol. 2006;24:5750–5762. - PubMed

Publication types